Error: Could not add to watchlist. X

Galapagos NV

+ Watchlist
GLPYY:US
Ticker Change
GLPYY:US has changed to a new ticker symbol
USD
Volume
0
Previous Close
43.20
Volume
0
Previous Close
43.20
Current P/E Ratio (TTM)
-
Earnings per Share (EUR) (TTM)
-
Market Cap (USD)
-
Shares Outstanding
-
Price/Sales (TTM)
-
Dividend Indicated Gross Yield
-
Sector
Health Care
Industry
Biotech & Pharma
Sub-Industry
Biotech

Related Videos

There are currently no related videos for this ticker. Please check back later.
There are currently no news stories for this ticker. Please check back later.
There are currently no press releases for this ticker. Please check back later.
Profile
Galapagos NV operates as a clinical stage biotech company. The Company develops and commercializes novel medicines and progressing pipelines in biotech with phase 2 programs, phase 1 programs, pre-clinical, and discovery programs.
ADDRESS
Generaal De Wittelaan L11 A3
Industriepark Mechelen Noord
Mechelen, 2800
Belgium
PHONE
32-15-34-2900
  • Onno Van De Stolpe
    CEO/Founder
  • Bart Filius
    Chief Financial Officer
  • Piet Wigerinck
    Chief Scientific Officer
  • Andre Hoekema
    Senior VP:Corporate Dev
  • Elizabeth Goodwin
    Head:Investor Relations
Show More